CABOT CORP (CBT)
CABOT CORP (CBT) from its SEC filings: 2025 revenue $3.7 billion (-7% vs the year before), net margin 9%, free cash flow $391.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Miscellaneous Chemical Products |
| Revenue (2025) | $3.7 billion |
| Revenue growth | -7% |
| Net income | $331.0 million |
| Net margin | 8.9% |
| Free cash flow | $391.0 million |
| Diluted EPS | $6.02 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +6% |
| Cash | $250.0 million |
| Long-term debt | $828.0 million |
| Share count, 1 year | -3% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.